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INTRODUCTION
Bisphosphonates are an important class of organophosphorus drugs known by their broad spectrum of therapeutic applications in the treatment of diseases characterized by abnormal calcium metabolism, due to their high affinity for calcium and target the bone mineral [1] [2] [3] [4] [5] . Bisphosphonates present other therapeutic applications against pathogenic agents due to their antiparasitic [6] [7] [8] , herbicidal [9] and antibacterial activities [10] . Bisphosphonates were also studied as ligands for radioactive metal complexes [11, 12] and as chelating agents for the treatment of human metal intoxications [13] .
The activity of bisphosphonates, in the treatment of bone disorders, is improved by the presence of a nitrogen containing group bonded to an alkyl moiety or to a heteroaromatic cycle [14] [15] [16] . Indazole, pyrazolo [3,4-b] pyridine, and pyrazolo [3,4-b] quinoline are heteroaromatic compounds with two or three nitrogen atoms in an aromatic moiety, resembling the heteroaromatic part of the most potent third-generation bisphosphonates, and are promising moieties for drug discovery.
Indazole, pyrazolo [3,4-b] pyridine and pyrazolo [3,4-b]quinoline have been studied, and a large
